Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.08
50% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Revenue | $4.3M | $5.4M | $5.5M | $6.7M | $9.2M | $12.6M | $17.7M |
| Cost of revenue | $3.5M | $4.4M | $4.4M | $5.4M | $6.7M | $10.2M | $14.5M |
| Gross profit | $776.5K | $942.6K | $1.0M | $1.4M | $1.9M | $2.4M | $3.2M |
| Gross margin | 18.2% | 17.5% | 19.1% | 20.1% | 20.1% | 18.7% | 18.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$21.0K | $206.1K | −$2.1M | −$2.2M | −$800.9K | −$579.6K | −$43.7K |
| EBITDA | −$10.0K | $219.6K | −$2.1M | −$2.2M | −$571.3K | −$1.2M | $1.5M |
| Net income | −$107.0K | $106.0K | −$11.6M | −$2.2M | $185.0K | −$2.2M | $1.2M |
| Net margin | -2.5% | 2.0% | -211.9% | -33.2% | 2.0% | -17.5% | 6.5% |
| EPS (diluted) | 0.00 | 0.08 | -0.29 | -0.05 | 0.00 | -0.02 | 0.01 |
Annual figures · source: Financial Modeling Prep
LEVELJUMP HEALTHCARE CP
No one on the platform currently holds JMPHF.
No tracked institution reports a position in JMPHF as of their last filing.
No one on the platform has traded JMPHF yet.
| $10M |
| — |
| HOOKHOOKIPA Pharma Inc. | $1.15 | +0.00% | $14M | — |
| LVCLFAlgorae Pharmaceuticals Limited | $0.01 | +17.90% | $16M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.2× sales vs its 0.4× historical median P/S.
Fair value ≈ $0.07 · price $0.04 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.